Skin cancer’s deadliness depends almost entirely on the type and how early it’s caught. Most skin cancers are highly survivable. Basal cell and squamous cell carcinomas, which account for the vast majority of cases, rarely kill. Melanoma is far more dangerous but still has an overall 5-year survival rate of 95% when all stages are combined. The real danger comes from late detection: a melanoma caught early has a greater than 99% survival rate, while one that has spread to distant organs drops to 35%.
The Three Main Types, Ranked by Danger
Not all skin cancers carry the same risk. Basal cell carcinoma is the most common and the least deadly. It grows slowly, almost never spreads to other parts of the body, and is typically cured with removal. Squamous cell carcinoma is slightly more aggressive and can occasionally metastasize, but deaths remain uncommon. Together, these two types kill an estimated 2,000 to 8,000 people per year in the United States, with squamous cell carcinoma responsible for most of those deaths.
Melanoma is the type most people fear, and for good reason. It accounts for a small fraction of skin cancer diagnoses but causes the majority of skin cancer deaths. An estimated 8,510 Americans will die of melanoma in 2026, out of roughly 112,000 new cases. Melanoma is more likely to invade deeper tissue and spread through the bloodstream to the lungs, liver, brain, or bones.
There is also a rare but particularly aggressive form called Merkel cell carcinoma. Even when caught at a localized stage, its 5-year survival rate is 79%, lower than localized melanoma. When it has spread to distant sites, that number is 31%. Merkel cell carcinoma is uncommon enough that most people will never encounter it, but it illustrates how widely skin cancer outcomes can vary by type.
How Stage at Diagnosis Changes Everything
The single biggest factor determining whether skin cancer kills is how far it has progressed when a doctor finds it. For melanoma, the contrast is stark:
- Localized (confined to the skin): greater than 99% 5-year survival
- Regional (spread to nearby lymph nodes): 76% 5-year survival
- Distant (spread to other organs): 35% 5-year survival
That gap between early and late detection is the difference between a minor outpatient procedure and a life-threatening illness. The good news is that most melanomas are caught at the localized stage, which is why the overall survival rate across all stages remains around 95%.
Merkel cell carcinoma follows a similar pattern but starts from a lower baseline. Localized cases have a 79% survival rate, regional cases 66%, and distant cases 31%. The combined survival across all stages is 69%, making it considerably more lethal than melanoma stage for stage.
Recurrence: A Risk That Lingers
Even after successful treatment, melanoma can come back. A large Danish study tracking patients diagnosed between 2008 and 2021 found that 10.6% of melanoma patients developed a recurrence. What makes recurrence particularly dangerous is where it shows up: among those whose melanoma returned, 56.6% had distant recurrence as their first sign of relapse. That means the cancer had already spread through the bloodstream to other organs rather than reappearing locally near the original site. This pattern makes regular follow-up monitoring important for years after initial treatment, especially for patients who had thicker or more advanced melanomas at diagnosis.
Who Faces Higher Risk
Fair-skinned people develop skin cancer far more often, but that doesn’t mean darker skin provides complete protection. People with darker skin tones are more likely to be diagnosed at a later stage, when the cancer is harder to treat. Melanomas in people of color often appear in less obvious locations, such as the palms, soles of the feet, or under fingernails, where they can go unnoticed longer.
People with weakened immune systems, whether from organ transplant medications, autoimmune conditions, or other causes, face elevated risks from squamous cell carcinoma in particular. Their tumors are more likely to behave aggressively and spread.
What Makes Skin Cancer More or Less Survivable
Several practical factors influence how dangerous any given skin cancer will be. Thickness of the tumor at diagnosis is one of the strongest predictors for melanoma. Thin melanomas (less than 1 millimeter deep) are almost always curable. Thicker tumors have had more time to grow downward into blood vessels and lymphatic channels, which is how they spread.
Location matters too. Melanomas on the trunk, head, and neck tend to have worse outcomes than those on the arms or legs, partly because they’re harder to spot early and partly because of the blood supply in those areas. Ulceration, where the surface of the melanoma has broken down, is another warning sign that the cancer is more aggressive.
The bottom line is that skin cancer spans a wide spectrum. A basal cell carcinoma on your nose is an inconvenience. A thick, ulcerated melanoma on your back that has reached your lymph nodes is a serious, potentially fatal disease. The type, the depth, and above all the timing of detection determine which end of that spectrum you land on.